Stocks / NASDAQ / VivoSim Labs Inc.

VivoSim Labs Inc.

Industry: Health Care – Biotechnology: Biological Products (No Diagnostic Substances)

Stock Symbol: VIVS – NASDAQ

Animal Usage: Animal Testing

Our Opinion

VivoSim Labs, Inc. is included on the Cruelty Free Investing use of animals list due to its historical involvement in animal testing. Under its former name, Organovo Holdings Inc., the company conducted pre-clinical studies using animal models—including rodents and large animals—to evaluate the functionality and durability of bioprinted therapeutic tissue patches. Although the company’s current and future focus is stated to be opposed to animal testing, its legacy operations and technical documentation confirm past use of animals in research and pre-clinical testing.

Supporting Evidence:

The company’s past corporate disclosures describe animal testing conducted during earlier research and development activities

“In the next 18 months, the Company expects to optimize its final liver tissue design and continue pre-GLP studies, including efficacy, safety and dosing studies in small animal disease models for IEMs.” Read the article for more details

Company Description

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Company Website: https://vivosim.ai

Contact: info@vivosim.ai